KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ardelyx (ARDX) over the last 13 years, with Q3 2025 value amounting to $42.7 million.

  • Ardelyx's Cash & Equivalents fell 993.91% to $42.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.7 million, marking a year-over-year decrease of 993.91%. This contributed to the annual value of $64.9 million for FY2024, which is 20243.13% up from last year.
  • According to the latest figures from Q3 2025, Ardelyx's Cash & Equivalents is $42.7 million, which was down 993.91% from $90.0 million recorded in Q2 2025.
  • In the past 5 years, Ardelyx's Cash & Equivalents registered a high of $96.1 million during Q4 2022, and its lowest value of $21.5 million during Q4 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $53.4 million (2022), whereas its average is $58.3 million.
  • As far as peak fluctuations go, Ardelyx's Cash & Equivalents plummeted by 7766.8% in 2023, and later soared by 20243.13% in 2024.
  • Over the past 5 years, Ardelyx's Cash & Equivalents (Quarter) stood at $72.4 million in 2021, then skyrocketed by 32.74% to $96.1 million in 2022, then plummeted by 77.67% to $21.5 million in 2023, then skyrocketed by 202.43% to $64.9 million in 2024, then plummeted by 34.22% to $42.7 million in 2025.
  • Its Cash & Equivalents was $42.7 million in Q3 2025, compared to $90.0 million in Q2 2025 and $30.8 million in Q1 2025.